Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): The GIMS (Glivec to Imatinib Switch) study

Maria Gemelli, Elena Maria Elli, Chiara Elena, Alessandra Iurlo, Tamara Intermesoli, Margherita Maffioli, Ester Pungolino, Maria Cristina Carraro, Mariella D'Adda, Francesca Lunghi, Michela Anghileri, Nicola Polverelli, Marianna Rossi, Mattia Bacciocchi, Elisa Bono, Cristina Bucelli, Francesco Passamonti, Laura Antolini, Carlo Gambacorti-Passerini

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Use of generic imatinib as first-line treatment in patients with chronic myeloid leukemia (CML): The GIMS (Glivec to Imatinib Switch) study'. Together they form a unique fingerprint.

Medicine & Life Sciences